Expertise in
8
conditions

Eric W. Van Den Neste

Brussels, BRU, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
Brussels, BRU, BE 

Overview

Eric Van Den Neste practices practicing medicine in Brussels, Belgium.

Mr. Van Den Neste is highly rated in 8 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 80 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Brussels, BRU 1000, Belgium
Other Locations
CHU UCL Namur, Godinne site, UCLouvain
Namur, WAL, Belgium
Leuven, VLG, Belgium
Cliniques Universitaires Saint Luc, Avenue Hippocrate 10, Saint-lambert, WAL 1200, Belgium
Yvoir, WAL, Belgium

Frequently Asked Questions about Eric W. Van Den Neste

Is Eric W. Van Den Neste a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Eric W. Van Den Neste is classified as an Distinguished expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Den Neste's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile